113 related articles for article (PubMed ID: 776847)
41. Minimum inhibitory and bactericidal dosages of rifampici against Mycobacterium leprae in the mouse foot pad: relationship to serum rifampicin concentrations.
Holmes IB
Int J Lepr Other Mycobact Dis; 1974; 42(3):289-96. PubMed ID: 4617716
[No Abstract] [Full Text] [Related]
42. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
[No Abstract] [Full Text] [Related]
43. Combinations of drugs against Mycobacterium leprae studied in mice.
Shepard CC
Int J Lepr Other Mycobact Dis; 1972; 40(1):33-9. PubMed ID: 4562383
[No Abstract] [Full Text] [Related]
44. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Walker LL; Van Landingham RM; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
[TBL] [Abstract][Full Text] [Related]
45. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
46. Comparative assessment of viability of M.leprae by mouse foot-pad and fluorescent staining techniques.
Sreevatsa ; Katoch VM
Indian J Lepr; 1994; 66(4):455-62. PubMed ID: 7714355
[TBL] [Abstract][Full Text] [Related]
47. [Secondary sulfone resistance--presentation of a case of leprosy-Oswaldo Cruz Foundation, Rio de Janeiro-Brazil].
Gallo ME; Damasco MH; Alburquerque EC; Silva TC; Almeida SM
Med Cutan Ibero Lat Am; 1989; 17(2):103-4. PubMed ID: 2666794
[TBL] [Abstract][Full Text] [Related]
48. The problem of dapsone-resistant leprosy.
Pearson JM
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):417-20. PubMed ID: 7042605
[No Abstract] [Full Text] [Related]
49. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
Dhople AM; Ibanez MA
Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
[TBL] [Abstract][Full Text] [Related]
50. Chemotherapy of leprosy in multibacillary nude mice.
Hastings RC; Chehl SK
Indian J Lepr; 1991; 63(3-4):350-5. PubMed ID: 1804889
[No Abstract] [Full Text] [Related]
51. Dapsone-resistant leprosy-the THELEP approach.
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):421-5. PubMed ID: 7042606
[No Abstract] [Full Text] [Related]
52. Secondary dapsone-resistant leprosy in Shanghai Municipality.
Ji BH; Chen JK; Zhang JL; Hou YH; Ni GX; Zhang RB
Lepr Rev; 1983 Sep; 54(3):197-202. PubMed ID: 6355724
[No Abstract] [Full Text] [Related]
53. Further experience with the kinetic method for the study of drugs against Mycobacterium leprae in mice. Activities of DDS, DFD, ethionamide, capreomycin and PAM 1392.
Shepard CC
Int J Lepr Other Mycobact Dis; 1969; 37(4):389-97. PubMed ID: 4918202
[No Abstract] [Full Text] [Related]
54. Reversal of drug resistance in Mycobacterium leprae by ampicillin/sulbactam.
Prabhakaran K; Harris EB; Randhawa B; Hastings RC
Microbios; 1992; 72(291):137-42. PubMed ID: 1287401
[TBL] [Abstract][Full Text] [Related]
55. Mycobacterium leprae persisters after treatment with dapsone and rifampicin.
Pattyn SR; Dockx P; Rollier MT; Rollier R; Saerens EJ
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):154-8. PubMed ID: 776851
[No Abstract] [Full Text] [Related]
56. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
[TBL] [Abstract][Full Text] [Related]
57. [Clinical and paraclinical aspects of secondary drug resistance to 4-4' diaminodiphenylsulfone in a population of leprosy patients in Bamako, Republic of Mali].
Baquillon G; Ferracci C; Diallo J; Saint-Andreé P; Pattyn SR
Acta Leprol; 1981; 85():40-52. PubMed ID: 6805234
[No Abstract] [Full Text] [Related]
58. Mouse foot pad technique for evaluation of drug resistance of M. leprae and other laboratory techniques to be used in leprosy control programmes.
Pattyn SR
Acta Leprol; 1983; 1(1):29-32. PubMed ID: 6401137
[TBL] [Abstract][Full Text] [Related]
59. "Drug-resistant proportion test" for M. leprae to quantify the proportion of drug-resistant M. leprae in a sample using the mouse foot pad.
Almeida JG; Joseph PS; Sarangapani G; Chacko CJ
Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):468-70. PubMed ID: 6399066
[TBL] [Abstract][Full Text] [Related]
60. Morphology of Mycobacterium leprae in tissue sections. Correlation with results of mouse foot pad inoculation.
Levy L; Fasal P; Murray LP
Arch Dermatol; 1969 Nov; 100(5):618-20. PubMed ID: 4187027
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
